EPO and left ventricular hypertrophy: Furthermore, animal studies in mice have shown that when EPO receptors (EPORs) are functional in cardiomyocytes, myocardial mass and cardiac function are maintained, while when EPORs are missing or not functional in cardiomyocytes, left ventricular hypertrophy develops and LVEF decreases despite increasing levels of EPO [15].